EUVIMEDEUVIMED entdecken
Open Access

Lutetium-177-PSMA therapy for recurrent/metastatic salivary gland cancer: a prospective pilot study

Niels J van Ruitenbeek, Maike J M Uijen, Chantal M L Driessen, Steffie M B Peters, Bastiaan M Privé, Adriana C H van Engen-van Grunsven, Mark W Konijnenberg, Martin Gotthardt, James Nagarajah, Carla M L van Herpen

Theranostics · 2024 · 14 (14) · 5388-5399

DOI: 10.7150/thno.99035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Niels J van Ruitenbeek und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Salivary Gland Neoplasms, Lutetium, Positron Emission Tomography Computed Tomography, Radioisotopes. Die Arbeit wurde bisher 13-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salivary Gland NeoplasmsLutetiumPositron Emission Tomography Computed TomographyRadioisotopesHumansPilot ProjectsMaleMiddle AgedProspective StudiesAgedFemaleNeoplasm Recurrence, LocalCarcinoma, Adenoid CysticCarcinoma, DuctalRadiopharmaceuticalsAdultAntigens, SurfaceGlutamate Carboxypeptidase II

Stichwörter der Autor:innen

(177)Lu-PSMA therapyAdenoid cystic carcinomaProstate-specific membrane antigenSalivary duct carcinomaSalivary gland cancer

Substanzen

LutetiumRadioisotopesLutetium-177RadiopharmaceuticalsFOLH1 protein, humanAntigens, SurfaceGlutamate Carboxypeptidase II

Autor:innen und Institutionen

  • Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Medical Imaging, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Pathology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Roentgeninstitut Duesseldorf, Duesseldorf, Germany.

Zitieren

APA

van Ruitenbeek, N. J., Uijen, M. J. M., Driessen, C. M. L., Peters, S. M. B., Privé, B. M., van Engen-van Grunsven, A. C. H., Konijnenberg, M. W., Gotthardt, M., Nagarajah, J., & van Herpen, C. M. L. (2024). Lutetium-177-PSMA therapy for recurrent/metastatic salivary gland cancer: a prospective pilot study. Theranostics, 14(14), 5388-5399. https://doi.org/10.7150/thno.99035

Vancouver

van Ruitenbeek NJ, Uijen MJM, Driessen CML, Peters SMB, Privé BM, van Engen-van Grunsven ACH, et al. Lutetium-177-PSMA therapy for recurrent/metastatic salivary gland cancer: a prospective pilot study. Theranostics. 2024;14(14):5388-5399. doi:10.7150/thno.99035

BibTeX
@article{vanRuitenbeek2024,
  author = {van Ruitenbeek, Niels J and Uijen, Maike J M and Driessen, Chantal M L and Peters, Steffie M B and Privé, Bastiaan M and van Engen-van Grunsven, Adriana C H and Konijnenberg, Mark W and Gotthardt, Martin and Nagarajah, James and van Herpen, Carla M L},
  title = {Lutetium-177-PSMA therapy for recurrent/metastatic salivary gland cancer: a prospective pilot study},
  journal = {Theranostics},
  year = {2024},
  volume = {14},
  number = {14},
  pages = {5388--5399},
  doi = {10.7150/thno.99035}
}
Kostenlos starten →